TRT and Cholesterol: Understanding Testosterone's Lipid Impact

Last Updated: May 2024

Men with low testosterone often grapple with adverse lipid profiles. A systematic review published in The Journal of Clinical Endocrinology & Metabolism in 2011 by Corona et al. found that men with total testosterone below 300 ng/dL had a significantly higher prevalence of metabolic syndrome, often including dyslipidemia [1]. This underscores a critical connection: insufficient testosterone is not just about libido or energy; it directly impacts metabolic health, including cardiovascular risk factors like cholesterol. The outdated lower bound of 264 ng/dL for “normal” testosterone, derived from a 1970s population that included sick and elderly individuals, frequently leaves men with symptomatic hypogonadism underserved and untreated, missing opportunities to address these underlying risks. Optimal health autonomy means understanding these connections and advocating for appropriate treatment when clinically indicated.

Understanding TRT’s Impact on Lipids

Testosterone replacement therapy (TRT) is a double-edged sword when it comes to lipid profiles. While restoring physiological testosterone levels can improve overall metabolic health in hypogonadal men, its direct effects on specific lipid markers, particularly HDL-C, warrant careful monitoring.

High-Density Lipoprotein Cholesterol (HDL-C)

Exogenous testosterone therapy commonly leads to a decrease in high-density lipoprotein cholesterol (HDL-C), often referred to as “good cholesterol.” This effect is generally dose-dependent and observed across various testosterone preparations. While the exact mechanism is complex, it is thought to involve hepatic lipase activity, which is upregulated by testosterone, leading to faster catabolism of HDL particles. A review by Bassil et al., published in Clinical Endocrinology in 2009, affirmed this consistent finding across multiple studies examining the effects of testosterone therapy on lipids and lipoproteins [2].

Low-Density Lipoprotein Cholesterol (LDL-C) and Triglycerides

The impact of TRT on low-density lipoprotein cholesterol (LDL-C) and triglycerides is more varied and less predictable than on HDL-C. Many studies report no significant change in LDL-C or triglycerides with TRT, especially when administered